Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer
Clinical trial NCT00541008 · COMPLETED
Trial details
- NCT number
- NCT00541008
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-05
- Primary completion
- 2011-02-01
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.